Literature DB >> 28284535

Depression symptoms and lost productivity in chronic rhinosinusitis.

Adam P Campbell1, Katie M Phillips1, Lloyd P Hoehle1, Allen L Feng1, Regan W Bergmark1, David S Caradonna2, Stacey T Gray1, Ahmad R Sedaghat3.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is associated with significant losses of patient productivity that cost billions of dollars every year. The causative factors for decreases in productivity in patients with CRS have yet to be determined.
OBJECTIVE: To determine which patterns of CRS symptoms drive lost productivity.
METHODS: Prospective, cross-sectional cohort study of 107 patients with CRS. Sinonasal symptom severity was measured using the 22-item Sinonasal Outcomes Test, from which sleep, nasal, otologic or facial pain, and emotional function subdomain scores were calculated using principal component analysis. Depression risk was assessed with the 2-item Patient Health Questionnaire (PHQ-2), whereas nasal obstruction was assessed with the Nasal Obstruction Symptom Evaluation (NOSE) instrument. Lost productivity was assessed by asking participants how many days of work and/or school they missed in the last 3 months because of CRS. Associations were sought between lost productivity and CRS symptoms.
RESULTS: A total of 107 patients were recruited. Patients missed a mean (SD) of 3.1 (12.9) days of work or school because of CRS. Lost productivity was most strongly associated with the emotional function subdomain (β = 7.48; 95% confidence interval [CI], 5.71-9.25; P < .001). Reinforcing this finding, lost productivity was associated with PHQ-2 score (β = 4.72; 95% CI, 2.62-6.83; P < .001). Lost productivity was less strongly associated with the nasal symptom subdomain score (β = 2.65; 95% CI, 0.77-4.52; P = .007), and there was no association between lost productivity and NOSE score (β = 0.01; 95% CI, -0.12 to 0.13; P = .91).
CONCLUSION: Symptoms associated with depression are most strongly associated with missed days of work or school because of CRS. Further treatment focusing on depression-associated symptoms in patients with CRS may reduce losses in productivity.
Copyright © 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28284535     DOI: 10.1016/j.anai.2016.12.012

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  13 in total

1.  Productivity changes following medical and surgical treatment of chronic rhinosinusitis by symptom domain.

Authors:  Daniel M Beswick; Jess C Mace; Luke Rudmik; Zachary M Soler; Adam S DeConde; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2018-07-28       Impact factor: 3.858

2.  Longitudinal improvement in nasal obstruction symptoms of chronic rhinosinusitis directly associates with improvement in mood.

Authors:  Marlene M Speth; Katie M Phillips; Lloyd P Hoehle; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-19       Impact factor: 2.503

3.  Seasonal variations in chronic rhinosinusitis symptom burden may be explained by changes in mood.

Authors:  Rehab Talat; Katie M Phillips; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-15       Impact factor: 2.503

4.  A contemporary analysis of clinical and demographic factors of chronic rhinosinusitis patients and their association with disease severity.

Authors:  L P Hoehle; K M Phillips; D S Caradonna; S T Gray; A R Sedaghat
Journal:  Ir J Med Sci       Date:  2017-05-30       Impact factor: 1.568

5.  Chronic rhinosinusitis disease burden is associated with asthma-related emergency department usage.

Authors:  Claire Gleadhill; Marlene M Speth; Isabelle Gengler; Katie M Phillips; Lloyd P Hoehle; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-04       Impact factor: 2.503

Review 6.  Local immunoglobulin production in nasal tissues: A key to pathogenesis in chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Kathryn E Hulse
Journal:  Ann Allergy Asthma Immunol       Date:  2020-10-13       Impact factor: 6.347

7.  The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights.

Authors:  D Dejaco; D Riedl; A Huber; R Moschen; A I Giotakis; L Bektic-Tadic; T Steinbichler; P Kahler; H Riechelmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-09       Impact factor: 2.503

8.  Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Erin Lewis; Deborah Gakpo; Jonathan Hacker; Aaqib Sohail; Faith Taliaferro; Evans Berreondo Giron; Chelsea Asare; Marko Vukovic; Jillian C Bensko; Daniel F Dwyer; Alex K Shalek; Jose Ordovas-Montanes; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2021-06-16       Impact factor: 14.290

9.  Association of the sinonasal bacterial microbiome with clinical outcomes in chronic rhinosinusitis: a systematic review.

Authors:  James C Wang; Charles A Moore; Madison V Epperson; Ahmad R Sedaghat
Journal:  Int Forum Allergy Rhinol       Date:  2020-02-13       Impact factor: 5.426

10.  Chronic rhinosinusitis control from the patient and physician perspectives.

Authors:  Ahmad R Sedaghat; Lloyd P Hoehle; Stacey T Gray
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.